Recombinant Human sodB Protein，His

SodB, or superoxide dismutase B, is an essential metalloenzyme that plays a critical role in protecting cells from oxidative stress by catalyzing the dismutation of superoxide radicals into oxygen and hydrogen peroxide. This enzyme is particularly important in various pathogenic bacteria, where it contributes to virulence by enhancing the organism's ability to withstand oxidative damage from the host's immune response. Research on SodB focuses on its structure, function, and potential applications in biotechnology and medicine. Typically found in both aerobic and anaerobic organisms, SodB has different isoforms in various species, each adapted to specific environmental conditions. The study of SodB’s structure has revealed crucial insights into its active site and the mechanisms by which it discriminates between superoxide and other radicals. Investigating the expression and regulation of the sodB gene can provide valuable information about bacterial pathogenicity and resistance mechanisms. Moreover, SodB has garnered interest as a potential therapeutic target for developing novel antibiotics, given its vital role in bacterial survival and pathogenesis. By inhibiting SodB activity, it may be possible to enhance the efficacy of existing antibiotics or develop new treatments against infections caused by multidrug-resistant bacteria. Advances in recombinant DNA technology have allowed for the production of SodB as a recombinant protein, enabling detailed studies of its enzymatic properties and interaction with other cellular components. Thus, research into SodB not only enhances our understanding of bacterial physiology but also opens new avenues for combating microbial infections and addressing public health challenges associated with antibiotic resistance.